Thirteen unauthorized products seized at various Ontario retailers may pose serious health risks

Starting date:
March 23, 2016
Posting date:
March 23, 2016
Type of communication:
Advisory
Subcategory:
Drugs, Chemicals
Source of recall:
Health Canada
Issue:
Important Safety Information, Product Safety
Audience:
General Public
Identification number:
RA-57642
Products affected
Retailer Product name Ingredient Indication Photo
One in Ten, 256 Bank St., Ottawa Ejaculoid Yohimbine sexual enhancement
One in Ten, 256 Bank St., Ottawa RSE7EN Desmethyl carbodenafil & dapoxetine sexual enhancement
One in Ten, 256 Bank St., Ottawa Extreme Diamond 2000 Desmethyl carbodenafil sexual enhancement
One in Ten, 256 Bank St., Ottawa Master Zone 1500 Sildenafil & tadalafil sexual enhancement
One in Ten, 256 Bank St., Ottawa Black Magic Sildenafil sexual enhancement
One in Ten, 256 Bank St., Ottawa Rock Hard Weekend Sildenafil sexual enhancement
One in Ten, 256 Bank St., Ottawa MV7 days 3500 Sildenafil & tadalafil sexual enhancement
One in Ten, 256 Bank St., Ottawa MV7 days 2000 Sildenafil & tadalafil sexual enhancement
One in Ten, 256 Bank St., Ottawa Black Panther Sildenafil & desmethyl carbodenafil & dapoxetine sexual enhancement
One in Ten, 256 Bank St., Ottawa & Private Pleasures, 5126 Dundas Street West, Etobocoke Mamba is Hero Sildenafil & dimethyl carbodenafil & dapoxetine sexual enhancement
One in Ten, 256 Bank St., Ottawa Black Mamba premium Desmethyl carbodenafil & dapoxetine sexual enhancement
BOSS Supplements, 411 Bayfield St., Barrie Animal Test Yohimbine Dietary supplements
Flex Plex, 1700 Dundas St. E, London Dust V2 Yohimbine Dietary supplements

 

Issue

Health Canada seized thirteen unauthorized drugs promoted for sexual enhancement or as bodybuilding supplements from four separate retailers in Ontario (see table below). The products were found to contain or were labelled to contain various prescription drug substances and other drug substances that may pose serious risks to the health of Canadians.

What you should do

Who is affected

Consumers who have purchased or used any of these products, particularly those with heart conditions.

Background

Sildenafil and tadalafil are prescription drug ingredients. Products containing these ingredients should only be used under the supervision of a health-care practitioner. Sildenafil and tadalafil should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat.  Other side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

Desmethyl carbondenafil is a substance similar to sildenafil and may pose similar health risks.

Dapoxetine is a drug ingredient. Side effects include seizures, changes in blood pressure, blurred vision, dizziness, headache and nausea.

Yohimbine is a prescription drug ingredient. Products containing yohimbine should only be used under the supervision of a health-care practitioner. The use of drugs containing yohimbine (either as yohimbine hydrochloride or yohimbe bark extract) may result in serious adverse reactions, particularly in people with high blood pressure, or heart, kidney or liver disease. Side effects associated with yohimbine include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, pregnant women or nursing women.

Report health or safety concerns

  • Call Health Canada toll-free at 1-866-234-2345.
  • Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Stay connected with Health Canada and receive the latest advisories and product recalls using
social media tools.

Media enquiries

Health Canada
(613) 957-2983

Public enquiries

(613) 957-2991
1-866 225-0709

What Health Canada is doing

Health Canada has seized the products from the retail locations. Should additional retailers or distributors of these products be identified, Health Canada will take appropriate action and inform Canadians.

Images

Select thumbnail to enlarge - opens in a new window